Singapore markets closed

Pressure BioSciences, Inc. (PBIO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.14000.0000 (0.00%)
At close: 12:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.19M
Enterprise value 27.99M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.76
Price/book (mrq)N/A
Enterprise value/revenue 14.15
Enterprise value/EBITDA -5.37

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-81.48%
S&P500 52-week change 323.76%
52-week high 30.8300
52-week low 30.1300
50-day moving average 30.2236
200-day moving average 30.3036

Share statistics

Avg vol (3-month) 361.98k
Avg vol (10-day) 366.3k
Shares outstanding 534.71M
Implied shares outstanding 634.71M
Float 834.46M
% held by insiders 10.64%
% held by institutions 10.00%
Shares short (30 Mar 2012) 46.34k
Short ratio (30 Mar 2012) 43
Short % of float (30 Mar 2012) 43.64%
Short % of shares outstanding (30 Mar 2012) 42.38%
Shares short (prior month 29 Feb 2012) 4107

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Jun 2017
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 305 Jun 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,117.74%

Management effectiveness

Return on assets (ttm)-388.31%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.98M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)-48.60%
Gross profit (ttm)N/A
EBITDA -9.39M
Net income avi to common (ttm)-27.95M
Diluted EPS (ttm)-1.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.28k
Total cash per share (mrq)0
Total debt (mrq)22.89M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.02
Book value per share (mrq)-0.93

Cash flow statement

Operating cash flow (ttm)-3.19M
Levered free cash flow (ttm)-18.26M